DULUTH HOLDINGS INC - CL B (DLTH)

US26443V1017 - Common Stock

2.93  +0.12 (+4.27%)

Fundamental Rating

1

DLTH gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 119 industry peers in the Specialty Retail industry. DLTH has a bad profitability rating. Also its financial health evaluation is rather negative. DLTH is valued expensive and it does not seem to be growing.



Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year DLTH has reported negative net income.
In the past year DLTH had a positive cash flow from operations.
DLTH had positive earnings in 4 of the past 5 years.
DLTH had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

The Return On Assets of DLTH (-6.22%) is worse than 72.41% of its industry peers.
Looking at the Return On Equity, with a value of -17.63%, DLTH is doing worse than 62.07% of the companies in the same industry.
Industry RankSector Rank
ROA -6.22%
ROE -17.63%
ROIC N/A
ROA(3y)1.43%
ROA(5y)2.18%
ROE(3y)3.33%
ROE(5y)5.52%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of DLTH (50.79%) is better than 78.45% of its industry peers.
In the last couple of years the Gross Margin of DLTH has declined.
The Profit Margin and Operating Margin are not available for DLTH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.07%
GM growth 5Y-1.66%

More info and screens

1

2. Health

2.1 Basic Checks

DLTH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DLTH has more shares outstanding
DLTH has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DLTH is higher compared to a year ago.

2.2 Solvency

DLTH has an Altman-Z score of 1.60. This is a bad value and indicates that DLTH is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.60, DLTH is doing worse than 65.52% of the companies in the same industry.
DLTH has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
DLTH has a Debt to Equity ratio (0.30) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 1.6
ROIC/WACCN/A
WACC9.87%

2.3 Liquidity

DLTH has a Current Ratio of 1.30. This is a normal value and indicates that DLTH is financially healthy and should not expect problems in meeting its short term obligations.
DLTH has a Current ratio (1.30) which is in line with its industry peers.
A Quick Ratio of 0.16 indicates that DLTH may have some problems paying its short term obligations.
The Quick ratio of DLTH (0.16) is worse than 91.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.16

More info and screens

1

3. Growth

3.1 Past

The earnings per share for DLTH have decreased strongly by -70.37% in the last year.
The Revenue has decreased by -1.86% in the past year.
Measured over the past years, DLTH shows a small growth in Revenue. The Revenue has been growing by 2.62% on average per year.
EPS 1Y (TTM)-70.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.12%
Revenue 1Y (TTM)-1.86%
Revenue growth 3Y0.41%
Revenue growth 5Y2.62%
Sales Q2Q%-8.07%

3.2 Future

DLTH is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -33.05% yearly.
Based on estimates for the next years, DLTH will show a decrease in Revenue. The Revenue will decrease by -0.09% on average per year.
EPS Next Y-113.38%
EPS Next 2Y-33.05%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.84%
Revenue Next 2Y-0.09%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DLTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DLTH. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

DLTH's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.56

4.3 Compensation for Growth

A cheap valuation may be justified as DLTH's earnings are expected to decrease with -33.05% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-33.05%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DLTH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DULUTH HOLDINGS INC - CL B

NASDAQ:DLTH (1/15/2025, 11:10:04 AM)

2.93

+0.12 (+4.27%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)12-05 2024-12-05/bmo
Earnings (Next)N/A N/A
Inst Owners26.42%
Inst Owner Change-0.39%
Ins Owners27.57%
Ins Owner Change0.45%
Market Cap103.08M
Analysts47.5
Price Target3.57 (21.84%)
Short Float %2.17%
Short Ratio4.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)30.66%
Min EPS beat(2)-25.61%
Max EPS beat(2)86.93%
EPS beat(4)1
Avg EPS beat(4)-5.48%
Min EPS beat(4)-60.42%
Max EPS beat(4)86.93%
EPS beat(8)3
Avg EPS beat(8)-137.98%
EPS beat(12)5
Avg EPS beat(12)-94.83%
EPS beat(16)8
Avg EPS beat(16)-6.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-7.57%
Max Revenue beat(2)6.71%
Revenue beat(4)1
Avg Revenue beat(4)-1.24%
Min Revenue beat(4)-7.57%
Max Revenue beat(4)6.71%
Revenue beat(8)2
Avg Revenue beat(8)-1.37%
Revenue beat(12)3
Avg Revenue beat(12)-1.63%
Revenue beat(16)5
Avg Revenue beat(16)-1.36%
PT rev (1m)-12.5%
PT rev (3m)-12.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.86%
EPS NY rev (1m)-180%
EPS NY rev (3m)-182.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.75%
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)-0.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.16
P/FCF N/A
P/OCF 8.92
P/B 0.55
P/tB 0.55
EV/EBITDA 12.56
EPS(TTM)-0.46
EYN/A
EPS(NY)-0.51
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)0.33
OCFY11.21%
SpS17.94
BVpS5.35
TBVpS5.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.22%
ROE -17.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.79%
FCFM N/A
ROA(3y)1.43%
ROA(5y)2.18%
ROE(3y)3.33%
ROE(5y)5.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.07%
GM growth 5Y-1.66%
F-Score3
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 3.64
Cap/Depr 44.66%
Cap/Sales 2.37%
Interest Coverage N/A
Cash Conversion 75.31%
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 0.16
Altman-Z 1.6
F-Score3
WACC9.87%
ROIC/WACCN/A
Cap/Depr(3y)87.38%
Cap/Depr(5y)82.8%
Cap/Sales(3y)4.19%
Cap/Sales(5y)3.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.12%
EPS Next Y-113.38%
EPS Next 2Y-33.05%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.86%
Revenue growth 3Y0.41%
Revenue growth 5Y2.62%
Sales Q2Q%-8.07%
Revenue Next Year-0.84%
Revenue Next 2Y-0.09%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-137.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year480.98%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y80.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.73%
OCF growth 3Y-8.66%
OCF growth 5Y4.46%